Soleno Therapeutics (SLNO) Net Cash Flow (QoQ) (2014 - 2026)
Soleno Therapeutics (SLNO) Net Cash Flow (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135.64% |
| Dec 31, 2025 | -203.73% |
| Sep 30, 2025 | 3,592.10% |
| Jun 30, 2025 | 26.12% |
| Mar 31, 2025 | -116.69% |
| Dec 31, 2024 | 558.89% |
| Sep 30, 2024 | -160.74% |
| Jun 30, 2024 | 111.18% |
| Mar 31, 2024 | -208.18% |
| Dec 31, 2023 | 254.54% |
| Sep 30, 2023 | 187.71% |
| Jun 30, 2023 | 270.84% |
| Mar 31, 2023 | -30.67% |
| Dec 31, 2022 | -19.36% |
| Sep 30, 2022 | 12.00% |
| Jun 30, 2022 | -163.91% |
| Mar 31, 2022 | 211.47% |
| Dec 31, 2021 | -27.17% |
| Sep 30, 2021 | 32.46% |
| Jun 30, 2021 | -5.17% |